Evidence map›Paper›PMID 39185428›Full record

ArticleRadiology case reports2024

Primary ovarian neuroendocrine carcinoma expressing substantially intense

Shiori Yamanaka-Mitsui, Noriko Oshima, Tamami Odai, Maki Takao, Kimio Wakana, Takumi Akashi, Junichi Tsuchiya, Naoyuki Miyasaka

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Radiology case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shiori Yamanaka-MitsuiDepartment of Obstetrics and Gynecology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Noriko OshimaDepartment of Obstetrics and Gynecology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Tamami OdaiDepartment of Obstetrics and Gynecology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Maki TakaoDepartment of Obstetrics and Gynecology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Kimio WakanaDepartment of Obstetrics and Gynecology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Takumi AkashiDepartment of Diagnostic Pathology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Junichi TsuchiyaDepartment of Diagnostic Radiology and Nuclear Medicine, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.
Naoyuki MiyasakaDepartment of Obstetrics and Gynecology, Tokyo Medical and Dental University, Tokyo 113-8519, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian neuroendocrine carcinoma is a rare and aggressive tumor with a poor prognosis. Ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) are often used for diagnosis. However, no specific features exist, and preoperative diagnosis is often difficult. We present a case in which ovarian neuroendocrine carcinoma was diagnosed postoperatively, with the intention to discuss its imaging features on

Indexed as

18F-FDG PET/CTGLUTKi67Ovarian neuroendocrine carcinomaSUVmax

Identifiers

PMID39185428
PMCPMC11342800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.